Search Results
1 - 11 of 11 matches
STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors
Presenter:
Sanjit Jolly
October 25, 2023
TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI
Presenter:
Byeong-Keuk Kim
October 14, 2020
TCT 621: STEMI in a Chronically Anticoagulated Patient Associated With a Coronary Artery Aneurysm: Cover it, Bypass it, or Treat it Medically?
Presenter:
Tuncay Taskesen
October 14, 2020
Adjunctive Pharmacotherapy During and After TAVR: Current Trends, New Studies, and the Case for Short-term (3-6 months) Systemic Anticoagulation
Presenter:
Eberhard Grube, James B. Hermiller Jr., Pascal Vranckx
November 1, 2017
Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!
Presenter:
A. Michael Lincoff, Franz-Josef Neumann, Harvey D. White
October 30, 2016
Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!
Presenter:
A. Michael Lincoff, Franz-Josef Neumann, Jorge F. Saucedo
October 30, 2016
Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!
Presenter:
A. Michael Lincoff, Franz-Josef Neumann
October 30, 2016
Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens
Presenter:
Harvey White
October 31, 2013
Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?
Presenter:
Andreas Baumbach, Bernardo Cortese, Efthymios Deliargyris, Gregg Stone, Harold Dauerman, Jayne Prats, Martial Hamon, Roxana Mehran
January 31, 2013
Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!
Presenter:
Roxana Mehran
October 25, 2012
Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!
Presenter:
Gilles Montalescot
October 25, 2012